Facilitated By

San Antonio Medical Foundation

News

  • Local biotech moving potential cancer drug closer to market

    Filled with “must read” stories, industry news and reporter insights, exclusive interviews with local business leaders, and expanded Top 25 Lists.

  • Rapamycin Holdings Plans Tests of Old Immune Drug in Prostate Cancer

    San Antonio — Executives at Rapamycin Holdings believe a decades-old drug used to prevent organ transplant rejection could find a new use as a ...

  • Cristal Glangchai Releases Venture Girls

    “They are just always making things and trying to sell things,” says Glangchai, who has a doctorate in biomedical engineering. “It's about having that ...

  • Ultragenyx: 1Q Earnings Snapshot

    The biotechnology company posted revenue of $10.7 million in the period, which did not meet Street forecasts. Ten analysts surveyed by Zacks ...

  • Twin Cities vie for Army innovation headquarters

    The Army will consider the quality and growth potential of local workforces in nine areas, including biomedical engineering, chemical engineering and ...